Drug Type Small molecule drug |
Synonyms Atorvastatin/CBD, Atorvo+ |
Target |
Mechanism CB1 modulators(Cannabinoid CB1 receptor modulators), HMG-CoA reductase modulators(HMG CoA reductase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC66H76CaF2N4O13 |
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N |
CAS Registry344423-98-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Disease | Phase 1 | AU | 18 Nov 2024 | |
Dyslipidemias | Phase 1 | AU | 18 Nov 2024 |